These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23027046)

  • 21. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing effective siRNAs with off-target control.
    Snøve O; Nedland M; Fjeldstad SH; Humberset H; Birkeland OR; Grünfeld T; Saetrom P
    Biochem Biophys Res Commun; 2004 Dec; 325(3):769-73. PubMed ID: 15541356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of putative miRNA binding sites and mRNA 3' ends as targets for siRNA-mediated gene knockdown.
    Bergauer T; Krueger U; Lader E; Pilk S; Wolter I; Bielke W
    Oligonucleotides; 2009 Mar; 19(1):41-52. PubMed ID: 19196098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of guanidinopropyl-modified siRNAs to silence gene expression.
    Buff MC; Bernhardt S; Marimani MD; Ely A; Engels JW; Arbuthnot P
    Methods Mol Biol; 2015; 1218():217-49. PubMed ID: 25319654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
    Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
    Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral delivery of small interfering RNA into primary cells.
    Barton GM; Medzhitov R
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14943-5. PubMed ID: 12417750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
    Groseth A; Hoenen T; Alimonti JB; Zielecki F; Ebihara H; Theriault S; Ströher U; Becker S; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S382-9. PubMed ID: 17940974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent and specific inhibition of retrovirus production by coexpression of multiple siRNAs directed against different regions of viral genomes.
    Ye K; Jin S
    Biotechnol Prog; 2006; 22(1):45-52. PubMed ID: 16454491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule.
    Furset G; Sioud M
    Biochem Biophys Res Commun; 2007 Jan; 352(3):642-9. PubMed ID: 17150189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small interfering RNA production by enzymatic engineering of DNA (SPEED).
    Luo B; Heard AD; Lodish HF
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5494-9. PubMed ID: 15024103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
    Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
    FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
    Rao DD; Maples PB; Senzer N; Kumar P; Wang Z; Pappen BO; Yu Y; Haddock C; Jay C; Phadke AP; Chen S; Kuhn J; Dylewski D; Scott S; Monsma D; Webb C; Tong A; Shanahan D; Nemunaitis J
    Cancer Gene Ther; 2010 Nov; 17(11):780-91. PubMed ID: 20596090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
    Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
    Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small interfering RNA for experimental cancer therapy.
    Tong AW; Zhang YA; Nemunaitis J
    Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.